Year-end Sale % OFF 
Abstract
Primary pulmonary artery sarcoma (PAS), which was first described by Mandelstamm in 1923,1 is a rare entity that is often misdiagnosed as chronic pulmonary thromboembolism.2 The differentiation of these 2 diseases with similar clinical presentations is fundamental for the initiation of adequate therapy, which completely differs between the 2 conditions.3 PAS often has a fatal outcome because of insidious intravascular tumor growth with extension into the distal pulmonary artery system. Surgery and adjacent irradiation or chemotherapy are necessary to optimize the survival time that ranges between 14 and 18 months.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of Thoracic and Cardiovascular Surgery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
